Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$397M |
| 2 |
NVIDIA
NVDA
|
+$373M |
| 3 |
AT&T
T
|
+$295M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$274M |
| 5 |
Walmart
WMT
|
+$273M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.19B |
| 2 |
Lam Research
LRCX
|
+$379M |
| 3 |
Apple
AAPL
|
+$367M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$320M |
| 5 |
Boeing
BA
|
+$299M |
Sector Composition
| 1 | Technology | 16.96% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Industrials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Sundial Growers
SNDL
$643M
| $123K | ﹤0.01% |
76,852
-43,009
| -36% | -$68.8K |
|
3927
Ultralife
ULBI
$114M
| $123K | ﹤0.01% |
30,546
+4,825
| +19% | +$19.4K |
|
3928
ReWalk Robotics
LFWD
$8.83M
| $123K | ﹤0.01% |
24,339
+4,481
| +23% | +$22.6K |
|
|
AEVA
3929
Aeva Technologies
AEVA
$911M
| $122K | ﹤0.01% |
20,432
+6,121
| +43% | +$36.5K |
|
|
SLN
3930
Silence Therapeutics
SLN
$223M
| $122K | ﹤0.01% |
19,684
+2,248
| +13% | +$13.9K |
|
|
ACHL
3931
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $122K | ﹤0.01% |
127,249
+45,494
| +56% | +$43.6K |
|
3932
Lufax Holding
LU
$2.63B
| $121K | ﹤0.01% |
14,888
+10,187
| +217% | +$82.8K |
|
3933
AquaBounty Technologies
AQB
$4.3M
| $120K | ﹤0.01% |
10,054
-3,252
| -24% | -$38.8K |
|
3934
Forge Global Holdings
FRGE
$225M
| $120K | ﹤0.01% |
+4,573
| New | +$120K |
|
3935
Lyra Therapeutics
LYRA
$10.3M
| $120K | ﹤0.01% |
+1,162
| New | +$120K |
|
3936
Purple Innovation
PRPL
$114M
| $120K | ﹤0.01% |
+45,397
| New | +$120K |
|
3937
BARK
BARK
$143M
| $119K | ﹤0.01% |
+82,303
| New | +$119K |
|
3938
Amplify Alternative Harvest ETF
MJ
$172M
| $119K | ﹤0.01% |
2,805
-7,481
| -73% | -$317K |
|
3939
Team
TISI
$82.7M
| $119K | ﹤0.01% |
21,746
-32,730
| -60% | -$179K |
|
3940
Alector
ALEC
$300M
| $118K | ﹤0.01% |
19,080
-31,422
| -62% | -$194K |
|
3941
Hagerty
HGTY
$1.26B
| $118K | ﹤0.01% |
13,514
-80,397
| -86% | -$702K |
|
3942
NexGen Energy
NXE
$4.82B
| $118K | ﹤0.01% |
30,807
-47,412
| -61% | -$182K |
|
3943
Identive
INVE
$85.9M
| $117K | ﹤0.01% |
19,047
-8,066
| -30% | -$49.5K |
|
3944
Crexendo
CXDO
$196M
| $116K | ﹤0.01% |
72,097
+29,399
| +69% | +$47.3K |
|
3945
Equillium
EQ
$102M
| $116K | ﹤0.01% |
+158,778
| New | +$116K |
|
3946
ReposiTrak
TRAK
$312M
| $116K | ﹤0.01% |
18,335
-3,496
| -16% | -$22.1K |
|
3947
Vivani Medical
VANI
$75.2M
| $116K | ﹤0.01% |
115,768
-22,564
| -16% | -$22.6K |
|
|
LUMO
3948
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $116K | ﹤0.01% |
34,342
+14,305
| +71% | +$48.3K |
|
3949
Momentus
MNTS
$14M
| $115K | ﹤0.01% |
281
+197
| +235% | +$80.6K |
|
3950
Pulse Biosciences
PLSE
$1.06B
| $115K | ﹤0.01% |
34,326
-10,719
| -24% | -$35.9K |
|